Follow
Matthias R. Lambert
Matthias R. Lambert
Boston Children's Hospital, Harvard Medical School
Verified email at childrens.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Involvement of O-GlcNAcylation in the skeletal muscle physiology and physiopathology: Focus on muscle metabolism
M Lambert, B Bastide, C Cieniewski-Bernard
Frontiers in endocrinology 9, 578, 2018
342018
O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins
B Deracinois, L Camoin, M Lambert, JB Boyer, E Dupont, B Bastide, ...
Journal of proteomics 186, 83-97, 2018
252018
O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle
C Cieniewski-Bernard, M Lambert, E Dupont, V Montel, L Stevens, ...
Frontiers in physiology 5, 421, 2014
182014
O-GlcNAcylation is a key modulator of skeletal muscle sarcomeric morphometry associated to modulation of protein–protein interactions
M Lambert, E Richard, S Duban-Deweer, F Krzewinski, B Deracinois, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (9), 2017-2030, 2016
172016
PDE10A inhibition reduces the manifestation of pathology in DMD Zebrafish and represses the genetic modifier PITPNA
MR Lambert, JM Spinazzola, JJ Widrick, A Pakula, JR Conner, JE Chin, ...
Molecular Therapy 29 (3), 1086-1101, 2021
112021
O‐GlcNAcylation as a regulator of the functional and structural properties of the sarcomere in skeletal muscle: An update review
M Lambert, C Claeyssen, B Bastide, C Cieniewski‐Bernard
Acta Physiologica 228 (1), e13301, 2020
102020
Multiplexed detection of O-GlcNAcome, phosphoproteome, and whole proteome within the same gel
C Cieniewski-Bernard, E Dupont, B Deracinois, M Lambert, B Bastide
Frontiers in endocrinology 5, 184, 2014
72014
Effect of serotonin modulation on dystrophin-deficient zebrafish
JM Spinazzola, MR Lambert, DE Gibbs, JR Conner, GL Krikorian, ...
Biology open 9 (8), bio053363, 2020
52020
Optimizing assays of zebrafish larvae swimming performance for drug discovery
JJ Widrick, MR Lambert, LM Kunkel, AH Beggs
Expert Opinion on Drug Discovery, 1-13, 2023
22023
Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy
MR Lambert, E Gussoni
Skeletal Muscle 13 (1), 18, 2023
2023
Jagged1 Ameliorates Dystrophic Phenotypes in Mouse Model of Duchenne Muscular Dystrophy
YT Zhang, MR Lambert, JJ Widrick, JR Conner, JM Spinazzola, ...
MOLECULAR THERAPY 30 (4), 501-502, 2022
2022
PRE-CLINICAL DEVELOPMENTS IN NEUROMUSCULAR DISORDERS: O. 13 Overexpression of JAG1 a therapeutic modifier for Duchenne muscular dystrophy
Y Zhang, M Lambert, J Widrick, J Conner, J Spinazzola, L Kunkel
Neuromuscular Disorders 31, S161, 2021
2021
DMD–ANIMAL MODELS: EP. 95 Downregulation of the genetic modifier PITPNA as means of therapy in Duchenne muscular dystrophy
M Lambert, Y Zhang, J Spinazzola, J Widrick, J Conner, L Kunkel
Neuromuscular Disorders 31, S78, 2021
2021
Overexpression of JAG1 a Disease Modifier for Duchenne Muscular Dystrophy Therapy
YT Zhang, MR Lambert, JJ Widrick, JR Conner, JM Spinazzola, ...
MOLECULAR THERAPY 29 (4), 294-295, 2021
2021
Caractérisation du rôle de la O-N-acétyl-glucosaminylation dans la structuration sarcomérique du muscle squelettique et de son implication dans certaines pathologies musculaires
M Lambert
Université de Lille, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–15